Gilead Sets a Good-Enough Bar With Covid-Treatment Price
Signage is displayed outside Gilead Sciences Inc. headquarters in Foster City, California, U.S. (Photographer: David Paul Morris/Bloomberg)

Gilead Sets a Good-Enough Bar With Covid-Treatment Price

Bookmark
(Bloomberg Opinion) -- Pricing a new medicine aimed at taming a pandemic is one of the touchiest scenarios imaginable for a drug company. Set the price too high, and the world will assail you for p...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.